Literature DB >> 32882016

HCT for CGD? Yes, and the sooner the better.

Emma C Morris1.   

Abstract

Entities:  

Year:  2020        PMID： 32882016     DOI： 10.1182/blood.2020007891

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood.

Authors:  James W Day; Reem Elfeky; Bethany Nicholson; Rupert Goodman; Rachel Pearce; Thomas A Fox; Austen Worth; Claire Booth; Paul Veys; Ben Carpenter; Rachael Hough; H Bobby Gaspar; Penny Titman; Deborah Ridout; Sarita Workman; Fernando Hernandes; Kit Sandford; Arian Laurence; Mari Campbell; Siobhan O Burns; Emma C Morris
Journal:  J Clin Immunol       Date:  2022-05-17       Impact factor: 8.542
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.